Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Research Alliance Corp III
13G
RACC · G75226103
|
14.1% |
10/7/2026
Event 9/30/2026
|
|||
| Nantahala Capital Management, LLC | 14.1% | ||||
| Wilmot B. Harkey | 14.1% | ||||
| Daniel Mack | 14.1% | ||||
|
Camping World Holdings, Inc.
13G/A
Amendment 1
CWH · 13462K109
|
7.2% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 7.2% | ||||
| Wilmot B. Harkey | 7.2% | ||||
| Daniel Mack | 7.2% | ||||
|
Peloton Interactive, Inc.
13G/A
Amendment 1
PTON · 70614W100
|
5.2% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 5.2% | ||||
| Wilmot B. Harkey | 5.2% | ||||
| Daniel Mack | 5.2% | ||||
|
Rallybio Corporation
13G/A
Amendment 1
RLYB · 75120L209
|
3.6% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 3.6% | ||||
| Wilmot B. Harkey | 3.6% | ||||
| Daniel Mack | 3.6% | ||||
|
Anteris Technologies Global Corp.
13G/A
Amendment 3
AVR · 03675P102
|
4.1% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 4.1% | ||||
| Wilmot B. Harkey | 4.1% | ||||
| Daniel Mack | 4.1% | ||||
|
Immunic, Inc.
13G/A
Amendment 2
IMUX · 4525EP200
|
7.5% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 7.5% | ||||
| Wilmot B. Harkey | 7.5% | ||||
| Daniel Mack | 7.5% | ||||
|
Quince Therapeutics, Inc.
13G/A
Amendment 3
QNCX · 22053A305
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Grace Therapeutics, Inc.
13G/A
Amendment 3
GRCE · 00439U104
|
6.8% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 6.8% | ||||
| Wilmot B. Harkey | 6.8% | ||||
| Daniel Mack | 6.8% | ||||
|
Avalo Therapeutics, Inc.
13G/A
Amendment 2
AVTX · 05338F306
|
3.5% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 3.5% | ||||
| Wilmot B. Harkey | 3.5% | ||||
| Daniel Mack | 3.5% | ||||
|
Inhibikase Therapeutics, Inc.
13G/A
Amendment 2
IKT · 45719W205
|
4.3% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 4.3% | ||||
| Wilmot B. Harkey | 4.3% | ||||
| Daniel Mack | 4.3% | ||||
|
TELA Bio, Inc.
13G/A
Amendment 3
TELA · 872381108
|
12.9% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 12.9% | ||||
| Wilmot B. Harkey | 12.9% | ||||
| Daniel Mack | 12.9% | ||||
|
Kiora Pharmaceuticals, Inc.
13G/A
Amendment 3
KPRX · 49721T507
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Fulcrum Therapeutics, Inc.
13G
FULC · 359616109
|
8.2% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 8.2% | ||||
| Wilmot B. Harkey | 8.2% | ||||
| Daniel Mack | 8.2% | ||||
|
Biomx Inc.
13G/A
Amendment 3
PHGE · 09090D509
|
7.1% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 7.1% | ||||
| Wilmot B. Harkey | 7.1% | ||||
| Daniel Mack | 7.1% | ||||
|
Unicycive Therapeutics, Inc.
13G/A
Amendment 10
UNCY · 90466Y202
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Eloxx Pharmaceuticals, Inc.
13G
ELOX · 29014R301
|
9.9% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 9.9% | ||||
| Wilmot B. Harkey | 9.9% | ||||
| Daniel Mack | 9.9% | ||||
|
Azitra, Inc.
13G
AZTR · 05479L302
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
ADC Therapeutics SA
13G
ADCT · H0036K147
|
9.7% |
8/14/2026
Event 6/30/2026
|
|||
| Nantahala Capital Management, LLC | 9.7% | ||||
| Wilmot B. Harkey | 9.7% | ||||
| Daniel Mack | 9.7% | ||||
|
Assertio Holdings, Inc.
13G/A
Amendment 3
ASRT · 04546C304
|
0% |
6/2/2026
Event 5/29/2026
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Abeona Therapeutics Inc.
13G/A
Amendment 5
ABEO · 00289Y206
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Herbalife Ltd.
13G/A
Amendment 3
HLF · G4412G101
|
6.7% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.7% | ||||
| Wilmot B. Harkey | 6.7% | ||||
| Daniel Mack | 6.7% | ||||
|
Anteris Technologies Global Corp.
13G/A
Amendment 2
AVR · 03675P102
|
6.3% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.3% | ||||
| Wilmot B. Harkey | 6.3% | ||||
| Daniel Mack | 6.3% | ||||
|
InspireMD, Inc.
13G/A
Amendment 5
NSPR · 45779A846
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Camping World Holdings, Inc.
13G
CWH · 13462K109
|
8.3% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 8.3% | ||||
| Wilmot B. Harkey | 8.3% | ||||
| Daniel Mack | 8.3% | ||||
|
Jack in the Box Inc.
13G
JACK · 466367109
|
8.1% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 8.1% | ||||
| Wilmot B. Harkey | 8.1% | ||||
| Daniel Mack | 8.1% | ||||
|
Edesa Biotech, Inc.
13G/A
Amendment 2
EDSA · 27966L306
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Envoy Medical, Inc.
13G
COCH · 29415V109
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Keros Therapeutics, Inc.
13G
KROS · 492327101
|
6.9% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.9% | ||||
| Wilmot B. Harkey | 6.9% | ||||
| Daniel Mack | 6.9% | ||||
|
Eventbrite, Inc.
13G/A
Amendment 2
EB · 29975E109
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Kiora Pharmaceuticals, Inc.
13G/A
Amendment 2
KPRX · 49721T507
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Opus Genetics, Inc.
13G/A
Amendment 3
IRD · 67577R102
|
6.5% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.5% | ||||
| Wilmot B. Harkey | 6.5% | ||||
| Daniel Mack | 6.5% | ||||
|
Peloton Interactive, Inc.
13G
PTON · 70614W100
|
7.3% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 7.3% | ||||
| Wilmot B. Harkey | 7.3% | ||||
| Daniel Mack | 7.3% | ||||
|
Noodles & Company
13G/A
Amendment 2
NDLS · 65540B303
|
9.5% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 9.5% | ||||
| Wilmot B. Harkey | 9.5% | ||||
| Daniel Mack | 9.5% | ||||
|
Quince Therapeutics, Inc.
13G/A
Amendment 2
QNCX · 22053A107
|
7.5% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 7.5% | ||||
| Wilmot B. Harkey | 7.5% | ||||
| Daniel Mack | 7.5% | ||||
|
Fossil Group, Inc.
13G/A
Amendment 3
FOSL · 34988V106
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Fox Factory Holding Corp.
13G/A
Amendment 1
FOXF · 35138V102
|
3.6% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 3.6% | ||||
| Wilmot B. Harkey | 3.6% | ||||
| Daniel Mack | 3.6% | ||||
|
Rallybio Corporation
13G
RLYB · 75120L209
|
5.7% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 5.7% | ||||
| Wilmot B. Harkey | 5.7% | ||||
| Daniel Mack | 5.7% | ||||
|
Fractyl Health, Inc.
13G/A
Amendment 1
GUTS · 35168W103
|
10.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Surrozen, Inc./DE
13G/A
Amendment 3
SRZN · 86889P208
|
2.1% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 2.1% | ||||
| Wilmot B. Harkey | 2.1% | ||||
| Daniel Mack | 2.1% | ||||
|
Fulcrum Therapeutics, Inc.
13G/A
Amendment 1
FULC · 359616109
|
4.6% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 4.6% | ||||
| Wilmot B. Harkey | 4.6% | ||||
| Daniel Mack | 4.6% | ||||
|
The Hain Celestial Group, Inc.
13G/A
Amendment 1
HAIN · 405217100
|
9.4% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 9.4% | ||||
| Wilmot B. Harkey | 9.4% | ||||
| Daniel Mack | 9.4% | ||||
|
Venu Holding Corporation
13G
VENU · 92333E104
|
6.6% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.6% | ||||
| Wilmot B. Harkey | 6.6% | ||||
| Daniel Mack | 6.6% | ||||
|
Gogo Inc.
13G/A
Amendment 1
GOGO · 38046C109
|
6.6% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.6% | ||||
| Wilmot B. Harkey | 6.6% | ||||
| Daniel Mack | 6.6% | ||||
|
Helix Acquisition Corp. III
13G
HLXC · G4444S107
|
8.3% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 8.3% | ||||
| Wilmot B. Harkey | 8.3% | ||||
| Daniel Mack | 8.3% | ||||
|
VYNE Therapeutics Inc.
13G
VYNE · 92941V308
|
6.0% |
5/15/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 6.0% | ||||
| Wilmot B. Harkey | 6.0% | ||||
| Daniel Mack | 6.0% | ||||
|
Curis, Inc.
13G
CRIS · 231269309
|
10.0% |
4/24/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Curis, Inc.
13G/A
Amendment 2
CRIS · 231269309
|
10.0% |
4/7/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Assertio Holdings, Inc.
13G/A
Amendment 2
ASRT · 04546C205
|
10.7% |
4/7/2026
Event 3/31/2026
|
|||
| Nantahala Capital Management, LLC | 10.7% | ||||
| Wilmot B. Harkey | 10.7% | ||||
| Daniel Mack | 10.7% | ||||
|
X4 Pharmaceuticals, Inc
13G/A
Amendment 1
XFOR · 98420X202
|
2.8% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 2.8% | ||||
| Wilmot B. Harkey | 2.8% | ||||
| Daniel Mack | 2.8% | ||||
|
Verastem, Inc.
13G/A
Amendment 4
VSTM · 92337C203
|
4.7% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 4.7% | ||||
| Wilmot B. Harkey | 4.7% | ||||
| Daniel Mack | 4.7% | ||||
|
Gogo Inc.
13G
GOGO · 38046C109
|
5.1% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 5.1% | ||||
| Wilmot B. Harkey | 5.1% | ||||
| Daniel Mack | 5.1% | ||||
|
Vistagen Therapeutics, Inc.
13G/A
Amendment 3
VTGN · 92840H400
|
4.7% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 4.7% | ||||
| Wilmot B. Harkey | 4.7% | ||||
| Daniel Mack | 4.7% | ||||
|
Unicycive Therapeutics, Inc.
13G/A
Amendment 9
UNCY · 90466Y202
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
The Hain Celestial Group, Inc.
13G
HAIN · 405217100
|
7.2% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 7.2% | ||||
| Wilmot B. Harkey | 7.2% | ||||
| Daniel Mack | 7.2% | ||||
|
Savara Inc.
13G/A
Amendment 1
SVRA · 805111101
|
3.6% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 3.6% | ||||
| Wilmot B. Harkey | 3.6% | ||||
| Daniel Mack | 3.6% | ||||
|
Fox Factory Holding Corp.
13G
FOXF · 35138V102
|
5.2% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 5.2% | ||||
| Wilmot B. Harkey | 5.2% | ||||
| Daniel Mack | 5.2% | ||||
|
Opus Genetics, Inc.
13G/A
Amendment 2
IRD · 67577R102
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Establishment Labs Holdings Inc.
13G/A
Amendment 7
ESTA · G31249108
|
3.5% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 3.4% | ||||
| Wilmot B. Harkey | 3.4% | ||||
| Daniel Mack | 3.5% | ||||
|
Korro Bio, Inc.
13G
KRRO · 500946108
|
6.4% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 6.4% | ||||
| Wilmot B. Harkey | 6.4% | ||||
| Daniel Mack | 6.4% | ||||
|
Elutia Inc.
13G/A
Amendment 3
ELUT · 05479K106
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Immunic, Inc.
13G/A
Amendment 1
IMUX · 4525EP101
|
8.2% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 8.2% | ||||
| Wilmot B. Harkey | 8.2% | ||||
| Daniel Mack | 8.2% | ||||
|
Edesa Biotech, Inc.
13G/A
Amendment 1
EDSA · 27966L306
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Inhibikase Therapeutics, Inc.
13G/A
Amendment 1
IKT · 45719W205
|
5.7% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 5.7% | ||||
| Wilmot B. Harkey | 5.7% | ||||
| Daniel Mack | 5.7% | ||||
|
DarioHealth Corp.
13G/A
Amendment 10
DRIO · 23725P308
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Herbalife Ltd.
13G/A
Amendment 2
HLF · G4412G101
|
8.4% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 8.4% | ||||
| Wilmot B. Harkey | 8.4% | ||||
| Daniel Mack | 8.4% | ||||
|
DHI Group, Inc.
13G
DHX · 23331S100
|
5.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 5.0% | ||||
| Wilmot B. Harkey | 5.0% | ||||
| Daniel Mack | 5.0% | ||||
|
BiomX Inc.
13G/A
Amendment 2
PHGE · 09090D509
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Bioventus Inc.
13G/A
Amendment 4
BVS · 09075A108
|
9.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 9.0% | ||||
| Wilmot B. Harkey | 9.0% | ||||
| Daniel Mack | 9.0% | ||||
|
Aprea Therapeutics, Inc.
13G/A
Amendment 1
APRE · 03836J201
|
4.5% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 4.5% | ||||
| Wilmot B. Harkey | 4.5% | ||||
| Daniel Mack | 4.5% | ||||
|
Anteris Technologies Global Corp.
13G/A
Amendment 1
AVR · 03675P102
|
7.5% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 7.5% | ||||
| Wilmot B. Harkey | 7.5% | ||||
| Daniel Mack | 7.5% | ||||
|
Anebulo Pharmaceuticals, Inc.
13G/A
Amendment 1
ANEB · 034569103
|
8.5% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 8.5% | ||||
| Wilmot B. Harkey | 8.5% | ||||
| Daniel Mack | 8.5% | ||||
|
Apyx Medical Corporation
13G/A
Amendment 1
APYX · 03837C106
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Grace Therapeutics, Inc.
13G/A
Amendment 2
GRCE · 00439U104
|
10.0% |
2/13/2026
Event 12/31/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Evoke Pharma Inc
13D/A
Amendment 5
EVOK · 30049G302
|
0% |
12/19/2025
Event 12/17/2025
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Harkey Wilmot B. | 0% | ||||
| Mack Daniel | 0% | ||||
|
Avalo Therapeutics, Inc.
13G/A
Amendment 1
AVTX · 05338F306
|
9.4% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 9.4% | ||||
| Wilmot B. Harkey | 9.4% | ||||
| Daniel Mack | 9.4% | ||||
|
InspireMD, Inc.
13G/A
Amendment 1
NSPR · 45779A846
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Fractyl Health, Inc.
13G
GUTS · 35168W103
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Establishment Labs Holdings Inc.
13G/A
Amendment 6
ESTA · G31249108
|
6.9% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 6.8% | ||||
| Wilmot B. Harkey | 6.8% | ||||
| Daniel Mack | 6.9% | ||||
|
Evolus, Inc.
13G/A
Amendment 1
EOLS · 30052C107
|
8.9% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 8.9% | ||||
| Wilmot B. Harkey | 8.9% | ||||
| Daniel Mack | 8.9% | ||||
|
Eventbrite, Inc.
13G/A
Amendment 1
EB · 29975E109
|
8.5% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 8.5% | ||||
| Wilmot B. Harkey | 8.5% | ||||
| Daniel Mack | 8.5% | ||||
|
Ehealth, Inc.
13G
EHTH · 28238P109
|
5.8% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 5.8% | ||||
| Wilmot B. Harkey | 5.8% | ||||
| Daniel Mack | 5.8% | ||||
|
enVVeno Medical Corporation
13G/A
Amendment 2
NVNO · 29415J106
|
3.5% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 3.5% | ||||
| Wilmot B. Harkey | 3.5% | ||||
| Daniel Mack | 3.5% | ||||
|
DarioHealth Corp.
13G/A
Amendment 9
DRIO · 23725P308
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
X4 Pharmaceuticals, Inc
13G
XFOR · 98420X202
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Verastem, Inc.
13G/A
Amendment 3
VSTM · 92337C203
|
7.1% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 7.1% | ||||
| Wilmot B. Harkey | 7.1% | ||||
| Daniel Mack | 7.1% | ||||
|
Destination XL Group, Inc.
13G
DXLG · 25065K104
|
8.4% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 8.4% | ||||
| Wilmot B. Harkey | 8.4% | ||||
| Daniel Mack | 8.4% | ||||
|
COMPASS Pathways plc
13G/A
Amendment 1
CMPS · 20451W101
|
3.6% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 3.6% | ||||
| Wilmot B. Harkey | 3.6% | ||||
| Daniel Mack | 3.6% | ||||
|
Vistagen Therapeutics, Inc.
13G/A
Amendment 2
VTGN · 92840H400
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Unicycive Therapeutics, Inc.
13G/A
Amendment 8
UNCY · 90466Y103
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Anteris Technologies Global Corp.
13G
AVR · 03675P102
|
5.3% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 5.3% | ||||
| Wilmot B. Harkey | 5.3% | ||||
| Daniel Mack | 5.3% | ||||
|
Theratechnologies Inc.
13G/A
Amendment 2
THTX · 88338H704
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Trisalus Life Sciences, Inc.
13G/A
Amendment 1
TLSI · 89680M101
|
4.1% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 4.1% | ||||
| Wilmot B. Harkey | 4.1% | ||||
| Daniel Mack | 4.1% | ||||
|
Third Harmonic Bio, Inc.
13G/A
Amendment 1
THRD · 88427A107
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 0% | ||||
| Wilmot B. Harkey | 0% | ||||
| Daniel Mack | 0% | ||||
|
Altisource Portfolio Solutions S.A.
13G
ASPS · L0175J104
|
8.4% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 8.4% | ||||
| Wilmot B. Harkey | 8.4% | ||||
| Daniel Mack | 8.4% | ||||
|
1 800 Flowers Com Inc
13G/A
Amendment 1
FLWS · 68243Q106
|
9.2% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 9.2% | ||||
| Wilmot B. Harkey | 9.2% | ||||
| Daniel Mack | 9.2% | ||||
|
Savara Inc.
13G
SVRA · 805111101
|
5.1% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 5.1% | ||||
| Wilmot B. Harkey | 5.1% | ||||
| Daniel Mack | 5.1% | ||||
|
RAPT Therapeutics, Inc.
13G/A
Amendment 1
RAPT · 75382E208
|
3.8% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 3.8% | ||||
| Wilmot B. Harkey | 3.8% | ||||
| Daniel Mack | 3.8% | ||||
|
Quince Therapeutics, Inc.
13G/A
Amendment 1
QNCX · 22053A107
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||
|
Nektar Therapeutics
13G/A
Amendment 1
NKTR · 640268306
|
2.2% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 2.2% | ||||
| Wilmot B. Harkey | 2.2% | ||||
| Daniel Mack | 2.2% | ||||
|
Kiora Pharmaceuticals, Inc.
13G/A
Amendment 1
KPRX · 49721T507
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| Nantahala Capital Management, LLC | 10.0% | ||||
| Wilmot B. Harkey | 10.0% | ||||
| Daniel Mack | 10.0% | ||||